Flightpath Biosciences is a startup based in the United States.
Flightpath Biosciences is a startup based in the United States.
Flightpath Biosciences develops targeted bacterial deletion therapies designed to selectively eliminate harmful gram-negative bacteria to treat infection-driven complex diseases such as colorectal cancer, Lyme disease, periodontal disease, and women's health conditions without harming the surrounding microbiome.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.